Incannex Healthcare Ltd

IXHL
2,55
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202414:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
28/2/202413:30GLOBEIncannex Announces Positive Topline Results from Phase 2..
16/2/202414:00EDGAR2Form 8-K - Current report
16/2/202413:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA..
14/2/202412:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202413:30EDGAR2Form 8-K - Current report
01/2/202413:30GLOBEClarion Clinics Open for Psychedelic-Assisted Treatments
24/1/202422:30EDGAR2Form 8-K - Current report
24/1/202422:05GLOBEIncannex Commences Dosing in Phase 2 Clinical Trial..
18/1/202415:08EDGAR2Form 8-K - Current report
18/1/202414:22GLOBEIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
17/1/202413:30GLOBEIncannex Receives IRB Approval for the RePOSA Phase 2/3..
17/1/202412:05EDGAR2Form 8-K - Current report
22/12/202312:07EDGAR2Form 8-K - Current report
22/12/202302:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:05GLOBEClarion Clinics Receives Ethics Board Endorsement for the..
20/12/202323:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202313:30GLOBEIncannex Update on IHL-42X Drug Candidate in Phase 2/3..
29/11/202319:40GLOBEIncannex Healthcare Announces Completion of..
16/11/202315:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202314:30GLOBEFederal Court of Australia Approves Incannex’s..
08/11/202312:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/9/202313:30GLOBEIncannex Announces Participation at the H.C. Wainwright 25th..
08/9/202312:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202314:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/8/202313:30GLOBEIncannex to Prepare FDA IND Application for..
22/8/202313:30GLOBEReview of IND Application for IHL-42X by US FDA has been..
08/8/202314:00GLOBEClarion Clinics Begins Accepting Registrations for..
08/8/202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202313:30GLOBEIncannex Healthcare June 2023 Quarterly Activities Report..
26/7/202313:30GLOBEIncannex Completes Positive Pre-IND Meeting with US FDA on..
21/7/202315:09GLOBEIncannex Submits IND Application to the US FDA for IHL-42X..
18/7/202313:40GLOBEIncannex engages Fortrea to Manage its FDA IND Opening Phase..
13/7/202314:00GLOBEIncannex Receives HREC Approval for Phase 2 Clinical Trial..
13/7/202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202314:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202313:30GLOBEIncannex Announces Intention to Redomicile to United States,..
06/7/202314:42GLOBEIncannex Receives Ethics Approval for..
23/6/202314:00GLOBEIncannex Announces Participation at the H.C. Wainwright 4th..
16/6/202314:00GLOBEIncannex Appoints Principal Investigators for IHL-42X Phase..
30/5/202314:00GLOBEWorld Renowned International Psychedelics Experts Join..
16/5/202313:50GLOBEIncannex Company Presentation – Presentation of Psychennex,..
05/5/202313:30GLOBEIncannex enters a lease for first psychedelic-assisted..
Apertura: Min: Max:
Chiusura: 2,55

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network